Billionaire Jeffrey Talpins Just Fled From These 5 Healthcare Stocks

3. Moderna, Inc. (NASDAQ:MRNA)

Former Value of Element Capital Management‘s 13F Position: $38.5 million

Number of Hedge Fund Shareholders: 41

Element Capital also built a new stake in Moderna, Inc. (NASDAQ:MRNA) during the fourth quarter, perhaps eyeing one of the 5 Stocks to Buy Before the Next Pandemic as an intriguing buy in the midst of the omicron variant’s rapid spread around the world. By Q1 however, the fund had unloaded its entire stake in the vaccine developer and biotech firm.

Moderna, Inc. (NASDAQ:MRNA) is far from done with Covid, as the company’s booster shots for the omicron variants appear to be poised for action come this fall after the FDA approved their use earlier this month. Those variants have proven to be even more transmissible than omicron itself, and the Biden administration has warned of yet another wave of Covid descending upon us later this year.

The latest news comes just two weeks after Moderna, Inc. (NASDAQ:MRNA)’s vaccine was also approved for use in children as young as six months old, opening another pathway to increased deliveries of vaccine doses. Moderna previously projected that its mRNA vaccine would generate $19 billion in sales this year, a figure that could rise substantially should the omicron variants gain a foothold.